z-logo
Premium
Fornix‐based trabeculectomy using the ‘anchoring’ corneal suture technique
Author(s) -
Ng Philip WC,
Yeung Barry YM,
Yick Doris WF,
Tsang Chiwai,
Lam Dennis SC
Publication year - 2003
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1046/j.1442-9071.2003.00620.x
Subject(s) - medicine , fornix , trabeculectomy , intraocular pressure , surgery , glaucoma , ophthalmology , fibrous joint , mitomycin c , glaucoma medication , hippocampus , endocrinology
Aim:  To assess the safety and efficacy of fornix‐based tra­beculectomy with the ‘anchoring’ corneal suture technique in Chinese patients. Methods:  A retrospective non‐comparative case series of 66 eyes of 63 Chinese patients who underwent fornix‐based trabeculectomy combined with intraoperative mitomycin C (MMC) 0.4 mg/mL for 2−5 min were studied. Conjunctival wound closure of all eyes was with the anchoring corneal suture technique using a 9−0 nylon suture to prevent leakage at the corneolimbal interface. The success rate, with or without anti‐glaucoma medication, the complication rate and the longevity of the drainage blebs were analyzed. Results:  At a mean follow‐up period of 447.36 ± 337.98 days, the mean intraocular pressure decreased from 26.83 ± 7.90 mmHg to 17.74 ± 8.74 mmHg ( P  < 0.001). The mean glaucoma medication decreased from 2.95 ± 0.98 preoperatively to 1.23 ± 1.41 postoperatively ( P  < 0.001). Thirty‐one eyes (47.0%) required no anti‐glaucoma medication postoperatively. Twenty eyes (30.3%) had qualified success postoperatively. Eight eyes (12.1%) had early wound leakage that resolved with conservative treatment. Three eyes (4.5%) required surgical repair. One eye (1.5%) had hypotonous maculopathy. No other major complications were encountered. Conclusion:  Fornix‐based trabeculectomy with adjunctive mitomycin C employing the anchoring corneal suture technique appears to be both safe and effective in Chinese patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here